Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 569-574 , July 2009

Optimization of automated large-scale production of [18F]fluoroethylcholine for PET prostate cancer imaging

  • Giancarlo Pascali

      Affiliations

    • Faculty of Medicine, University of Pisa, 56100 Pisa, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 050993121; fax: +39 050993637.
  • ,
  • Luca D'Antonio

      Affiliations

    • Nuclear Medicine, IRCCS-Ospedale Maggiore, 20122 Milan, Italy
  • ,
  • Paola Bovone

      Affiliations

    • Nuclear Medicine, IRCCS-Ospedale Maggiore, 20122 Milan, Italy
  • ,
  • Paolo Gerundini

      Affiliations

    • Nuclear Medicine, IRCCS-Ospedale Maggiore, 20122 Milan, Italy
  • ,
  • Thorsten August

      Affiliations

    • Eckert and Ziegler EURO-PET Berlin GmbH, 12435 Berlin, Germany

Received 9 October 2008 ,Revised 2 January 2009 ,Accepted 5 January 2009.

References 

  1. Hara T, Kosaka N, Kishi H. Development of 18F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med. 2002;43:187–199
  2. Price DT, Coleman E, Liao RP, et al. Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168:273–280
  3. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992;5:303–324
  4. De Certaines JD, Larsen VA, Podo F, et al. In vivo 31P MRS of experimental tumors: a review. NMR Biomed. 1993;6:345–365
  5. Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med. 1997;38:842–847
  6. Hara T, Inagaki K, Kosaka N, Morita T. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J Nucl Med. 2000;41:1507–1513
  7. Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using 11C-choline and 18F-fluorodeoxyglucose. Cancer. 1999;86:1638–1648
  8. Hara T, Kosaka N, Kondo T, Kishi H, Kobori O. Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with [C-11]choline [abstract]. J Nucl Med. 1997;38(Suppl):250P
  9. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990–995
  10. Deves R, Krupka RM. The binding and translocation steps in transport as related to substrate structure: a study of the choline carrier of erythrocytes. Biochim Biophys Acta. 1979;557:469–485
  11. Yu HK, Park JH, Yang SD. Synthesis of [18F]fluorocholine analogues as a potential imaging agent for PET studies. Bull Korean Chem Soc. 2004;25(4):506–509
  12. DeGrado TR, Coleman RE, Wang S, et al. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res. 2000;61:110–117
  13. DeGrado TR, Baldwin SW, Wang S, et al. Synthesis and evaluation of 18F-labeled choline analogs as oncologic PET tracers. J Nucl Med. 2001;42:1805–1814
  14. DeGrado TR, Reiman RE, Price DT, et al. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med. 2002;43:92–96
  15. web source: http://clinicaltrials.gov/show/NCT00520546
  16. web source: http://clinicaltrials.gov/show/NCT00670527
  17. Piel M, Bauman A, Baum RP, Höhnemann S, Klette I, Wortmann R, et al. Improved automated synthesis of [18F]fluoroethylcholine as a radiotracer for cancer imaging. Bioorg Med Chem. 2007;15:3171–3175
  18. European Pharmacopeia 6.0, vol.1, chap.5.4, 604-610.
  19. Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivates. Semin Nucl Med. 2007;37:420–428
  20. Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008;49:1187–1194
  21. Rosen MK, Jones RM, Yano Y, Budinger TF. Carbon-11 choline: synthesis, purification, and brain uptake inhibition by 2-dimethylaminoethanol. J Nucl Med. 1985;26:1424–1428
  22. Henriksen G, Herz M, Hauser A, Schwaiger M, Wester HJ. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC). Nuc Med Biol. 2004;31:851–858
  23. Kwee S, Turner H, Lim J, Wakano C, Coel M. Dimethylaminoethanol reduces [18F]fluoroethylcholine uptake in prostate cancer cells. J Nucl Med. 2006;47(Suppl 1):425P
  24. http://www.eurotope.de/products/modular_lab_syntheses/.

PII: S0969-8051(09)00005-5

doi: 10.1016/j.nucmedbio.2009.01.004

Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 569-574 , July 2009